Adnexus, A Bristol-Myers Squibb R&D Company
Adnexus, A Bristol-Myers Squibb R&D Company Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20080220049 | Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins - The present disclosure relates to novel sustained-release intraocular drug delivery systems and improvements in the treatment of retinopathies. In particular, fibronectin scaffold domain proteins that selectively inhibit VEGFR-2 are contemplated. | 09-11-2008 |